Several other plays have come in nicely, with Curis (CRIS) ascending into the range I thought they would hit ($3), the stock just needed time. We have sold 1/2 of our CRIS position, making the rest a free ride (in at $1.44 average). Trius Therapeutics (TSRX) has come in nicely for a $1 gain, and Genoptix (GXDX) is getting some love. Time will tell.
10 expert stock picks for 2011
So if you had just one pick for 2011, one single stock to buy now and sell 365 days later, what would you pick? That’s exactly the question I put to 10 of Wall Street’s sharpest minds — well, nine and then my own — and I wasn’t surprised to find a common theme. Namely, that the biggest potential lies in tech and financials.Read More...
Interesting Biotech Picks for 2011
First, I thought that readers would like to follow my picks on a spreadsheet. I have one (below) and will update it here, so bookmark for future reference. I will do my best to keep it up to date and will most likely post updates at weeks end.Read More...
Best Biotech Stock for 2011 – Zalicus (ZLCS)
Zalicus (NASDAQ: ZLCS) is my top pick for an unknown biotech winner in 2011, narrowly beating out Antares Pharmaceuticals (AMEX: AIS). Both are great biotech stocks, but ZLCS is my favorite.Read More...
Top Biotech Stocks for 2011 and January
Top Biotech Picks for 2011, Stocks Highlighted at the JP Morgan Healthcare Conference, News on Human Genome Sciences, Dendreon, Bargain Biotech Stocks, and January FDA Catalysts.Read More...
Tag ; top biotech picks 2012, top biotech picks 2011, top biotech predictions 2011, top pharma picks 2011, top biotech pictures 2011, For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment